Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) and Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations. Insider & Institutional Ownership 71.6% of Acrivon […]

Bio-Path (NASDAQ:BPTH – Get Free Report) and Turn Therapeutics (NASDAQ:TTRX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Insider and Institutional Ownership 5.7% of Bio-Path shares […]